These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31332047)

  • 1. Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.
    Yeung TL; Leung CS; Yip KP; Sheng J; Vien L; Bover LC; Birrer MJ; Wong STC; Mok SC
    Clin Cancer Res; 2019 Nov; 25(21):6417-6428. PubMed ID: 31332047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
    Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
    FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling.
    Chen Z; Yan X; Li K; Ling Y; Kang H
    Clin Transl Oncol; 2020 Apr; 22(4):522-531. PubMed ID: 31190277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix.
    Duan Y; Zhang X; Ying H; Xu J; Yang H; Sun K; He L; Li M; Ji Y; Liang T; Bai X
    Oncogene; 2023 Jun; 42(25):2061-2073. PubMed ID: 37156839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
    Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
    J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer.
    Li Q; Zhang Y; Jiang Q
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):51-58. PubMed ID: 30454902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
    Wu Z; Wang T; Fang M; Huang W; Sun Z; Xiao J; Yan W
    Biochem Biophys Res Commun; 2018 Apr; 498(3):495-501. PubMed ID: 29526753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
    Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
    Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.
    Principe S; Mejia-Guerrero S; Ignatchenko V; Sinha A; Ignatchenko A; Shi W; Pereira K; Su S; Huang SH; O'Sullivan B; Xu W; Goldstein DP; Weinreb I; Ailles L; Liu FF; Kislinger T
    J Proteome Res; 2018 Jun; 17(6):2045-2059. PubMed ID: 29681158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker.
    Kujawa KA; Zembala-Nożynska E; Syrkis JP; Cortez AJ; Kupryjańczyk J; Lisowska KM
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
    Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
    Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfibril-associated protein 5 and the regulation of skin scar formation.
    Han C; Leonardo TR; Romana-Souza B; Shi J; Keiser S; Yuan H; Altakriti M; Ranzer MJ; Ferri-Borgogno S; Mok SC; Koh TJ; Hong SJ; Chen L; DiPietro LA
    Sci Rep; 2023 May; 13(1):8728. PubMed ID: 37253753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
    Leung CS; Yeung TL; Yip KP; Pradeep S; Balasubramanian L; Liu J; Wong KK; Mangala LS; Armaiz-Pena GN; Lopez-Berestein G; Sood AK; Birrer MJ; Mok SC
    Nat Commun; 2014 Oct; 5():5092. PubMed ID: 25277212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway.
    Li JH; Zhu XX; Li FX; Huang CS; Huang XT; Wang JQ; Gao ZX; Li SJ; Xu QC; Zhao W; Yin XY
    J Exp Clin Cancer Res; 2019 Nov; 38(1):476. PubMed ID: 31775892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.
    Secq V; Leca J; Bressy C; Guillaumond F; Skrobuk P; Nigri J; Lac S; Lavaut MN; Bui TT; Thakur AK; Callizot N; Steinschneider R; Berthezene P; Dusetti N; Ouaissi M; Moutardier V; Calvo E; Bousquet C; Garcia S; Bidaut G; Vasseur S; Iovanna JL; Tomasini R
    Cell Death Dis; 2015 Jan; 6(1):e1592. PubMed ID: 25590802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
    Qu C; Wang Q; Meng Z; Wang P
    Integr Cancer Ther; 2018 Dec; 17(4):1016-1019. PubMed ID: 30136592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.